Sacra estimates Commure hit $105M in annual recurring revenue in March 2024, growing 150% YoY. As of June 2025, Commure stated that ARR had doubled for three consecutive years, implying the company has sustained its growth trajectory well into the hundreds of millions of dollars.

The revenue mix comes primarily from two key segments: Athelas' revenue cycle management and remote patient monitoring products serving thousands of healthcare providers, and Commure's enterprise software business serving major health systems like HCA Healthcare, Jefferson, and Providence. The Augmedix acquisition adds an additional revenue stream through medical documentation services.

Commure's platform now processes tens of billions of dollars in annual payments across more than 500 healthcare organizations and 3,000+ sites of care. Key growth drivers include expansion of RCM products, enterprise-wide deployments of clinical documentation AI, and cross-selling across its growing health system customer base. The company maintains an active M&A pipeline to supplement organic growth.

In May 2026, Commure raised $70M led by General Catalyst, with participation from Sequoia Capital, Morgan Stanley, and Kirkland & Ellis, at a $7B post-money valuation. This follows a $200M growth financing deal in June 2025 from General Catalyst's Customer Value Fund, which Commure structured to allow expansion without dilution. The prior $6B valuation was established at the time of the Athelas merger. General Catalyst has served as lead backer across rounds.

Commure was founded in 2017 by Hemant Taneja at General Catalyst, alongside former leaders from Google, Salesforce, and Health Catalyst. The company initially launched as a developer platform for healthcare applications but pivoted to focus on enterprise healthcare software solutions.

The core product, Commure Scribe, listens to physician-patient interactions and creates structured medical notes in real-time, integrating with more than 60 different EHR systems including Epic and Cerner. The ambient AI suite supports tens of millions of appointments each year, with physicians requiring minimal editing of generated notes.

Beyond clinical documentation, Commure offers a comprehensive healthcare operations suite including staff safety solutions with wearable smart badges, automated revenue cycle management tools, and a patient engagement platform. All products are built on CommureOS, their healthcare-specific operating system that enables seamless integration across a health system's existing technology infrastructure. The platform is deployed across more than 130 large health systems, including HCA Healthcare and Tenet Healthcare, spanning 3,000+ sites of care.

Commure is a healthcare software company that sells enterprise solutions to major health systems, monetizing through customized subscriptions for its suite of AI-powered tools and platforms.

The company's core products include ambient AI documentation (Scribe), revenue cycle management automation, remote patient monitoring, and staff safety solutions.

The company prices its solutions through enterprise-wide contracts, with annual commitments typically starting at $1 million for access to specific modules. Pricing scales based on the size of the healthcare organization and number of modules deployed. Healthcare systems can start with a single solution like Scribe for clinical documentation and expand into additional modules over time.

Commure's platform completes more than 85% of revenue-cycle work without human intervention, underpinning its value proposition to customers and supporting high-margin, scalable delivery. The company is expanding its go-to-market motion beyond large health systems into specialty practices and integrated delivery networks, and is extending its infrastructure into healthcare markets outside the US.

Commure's competitive advantage stems from its integrated platform approach — healthcare organizations can deploy multiple solutions that work together seamlessly, increasing switching costs over time. Its merger with Athelas and acquisition of Augmedix further strengthen this platform strategy by expanding capabilities in remote monitoring and clinical documentation.

Commure operates in the healthcare software and AI automation market, competing across several distinct segments focused on clinical workflow optimization and administrative automation.

Epic Systems dominates the traditional enterprise healthcare software market with its comprehensive EHR and hospital management systems. Cerner (now part of Oracle) and Allscripts also maintain significant market share in this segment. These incumbents offer broad functionality but are often criticized for creating documentation burden and workflow inefficiencies that Commure aims to address.

Microsoft's Nuance leads in clinical documentation with its Dragon Medical platform. Emerging competitors include Abridge, which focuses on specialty-specific AI scribing, and Suki, which offers both documentation and virtual assistant capabilities. Recent entrant Ambience Healthcare has gained traction with its specialty-focused approach. This segment has seen increased competition as providers seek solutions to reduce physician burnout.

R1 RCM and Change Healthcare (now part of Optum) dominate traditional revenue cycle management. Olive AI attempted to automate healthcare administrative tasks before shutting down in 2023. Notable startups like Notable Health and Health Note focus on specific workflow automation niches. The RCM space has attracted significant private equity investment, with firms consolidating point solutions into broader platforms.

The competitive landscape is shifting as health systems increasingly seek integrated solutions that combine clinical documentation, workflow automation, and revenue cycle management. This has driven consolidation through acquisitions, as evidenced by Commure's purchases of PatientKeeper, Strongline, and Augmedix.

Commure has tailwinds from the massive shift toward AI-enabled healthcare automation and has the opportunity to expand into adjacent markets beyond its current focus on clinical documentation and revenue cycle management.

The healthcare enterprise software market represents a $30B+ opportunity. Commure's ambient AI platform, validated through partnerships with major health systems like HCA Healthcare and Tenet, positions them to expand beyond documentation into areas like clinical decision support, care coordination, and operational analytics. Their acquisition of Augmedix demonstrates their ability to integrate complementary technologies and scale rapidly.

Healthcare administrative costs exceed $1T annually in the US. Commure's RCM platform already processes tens of billions of dollars in annual payments. By expanding into more sophisticated prior authorization automation, eligibility verification, and denial management, they can capture a larger share of this market while delivering measurable ROI to customers through improved efficiency and accuracy.

The clinical documentation burden costs the US healthcare system an estimated $90B annually in physician time. Their platform's ability to integrate with 60+ EHR systems positions them to expand into automated order entry, care planning, and quality measure reporting — addressing an additional $50B+ market opportunity as healthcare organizations seek comprehensive workflow automation solutions.

International healthcare systems face similar administrative burdens to those in the US, and Commure's EHR-agnostic platform architecture supports deployment across varied health IT environments. The company has earmarked a portion of its recent financing to extend its infrastructure into healthcare markets outside the US, establishing global expansion as a near-term growth vector alongside its domestic push into specialty practices and integrated delivery networks.

Integration complexity: Commure's acquisitions of PatientKeeper, Strongline, and Augmedix create significant technical complexity in building a cohesive platform. Health systems are notoriously slow to change established workflows, and integration issues could severely impact adoption rates.

Dependence on strategic relationships: Commure's growth is heavily tied to partnerships with major health systems like HCA Healthcare and General Catalyst's health system network. If these relationships deteriorate, it could significantly limit the company's market access and growth trajectory.

AI competitive differentiation: As ambient AI and clinical documentation become increasingly commoditized, Commure faces intense competition from both established players like Microsoft's Nuance and well-funded startups. Its broad product portfolio could dilute its ability to maintain technological leadership in areas where specialized competitors are solely focused on perfecting specific use cases.